Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nesa Medtech is a private women's health medical device company based in Bengaluru, India, focused on minimally invasive and scarless treatment solutions for symptomatic uterine fibroids. Its flagship product, GYIDE, is a uterus-preserving image-guided system designed to plan and guide fibroid treatment, including real-time ultrasound-guided ablation workflows. The company has also developed the Fibroid Mapping Reviewer Application (FMRA), a software application cleared by the U.S. FDA to generate 3D uterine models from ultrasound images for diagnosis and procedure planning. Nesa positions itself as a deep-tech medtech company seeking to replace more invasive gynecologic interventions with office-based or less invasive alternatives. The business appears centered on women’s health device innovation rather than therapeutics or a broad multi-asset drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nesa Medtech.